drugset / Trial / NCT00874354

Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction

NCT00874354 ↗

Phase 1 Completed 27 enrolled Cedars-Sinai Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This research is being done because currently there is no effective way in regenerating or replacing the heart muscle that has been damaged after a heart attack. The purpose of this study is to test whether injecting cells obtained from the patient's bone marrow into the coronary artery can regenerate and replace heart tissue to strengthen heart and prevent heart from dilating and developing heart failure.

Timeline

Start
2005-07
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous bone marrow-derived mononuclear cells Cell therapy 50 ml Other
Subject autologous bone marrow-derived mononuclear cells Cell therapy 100 ml Other

Indications